Clinical trials recruiting for Heart failure
1,021
Recruiting trials
50
US states with sites
87
Countries
11%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 92 |
| California | 91 |
| New York | 79 |
| Ohio | 73 |
| Florida | 69 |
| Massachusetts | 66 |
| Minnesota | 66 |
| North Carolina | 65 |
| Illinois | 61 |
| Pennsylvania | 61 |
| Virginia | 56 |
| Michigan | 54 |
Top cities
New York, New York 64Boston, Massachusetts 63Dallas, Texas 58Chicago, Illinois 48Houston, Texas 48Cleveland, Ohio 45San Francisco, California 39Durham, North Carolina 38Rochester, Minnesota 37Philadelphia, Pennsylvania 36
Self-screener
Recruiting trials
- 18F-mFBG Imaging for Myocardial Sympathetic Innervation
- 30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital
- 3D Assessment of RV Function in Patients Undergoing LVAD Implantation
- : Vascular Function in Health and Disease
- A Clinical Study of Association Between Postoperative Dyslipidemia and Organ Rejection in Transplant Patients
- A Clinical Study of HRS-5765 in Healthy Participants
- A Clinical Study of HRS-7156 in Healthy Participants
- A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin
- A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
- A Cohort Study on Early Stages of Heart Failure
- A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure
- A Feasibility Study Implant of the WiSE® CRT System With an Intracardiac Pacemaker to Achieve Totally Leadless CRT
- A Multi-center Cardiac PYP Scan Registry in Taiwan
- A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System
- A Nurse-Led Weight Monitoring Intervention For Heart Failure Quality of LIfe and Self-Care
- A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
- A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
- A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction
- A Photoplethysmography-Based Machine Learning Algorithm for Early Atrial Fibrillation Detection: A Prospective Validation Study
- A Pilot Randomized Controlled Trial Comparing Core Exercise, Aerobic Exercise, and Combined Exercise in Patients Undergoing Phase II Cardiac Rehabilitation.
- A Pivotal Clinical Trial of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advanced Heart Failure(NYHA III-IV)
- A Portable Thoracic Impedance Device for Detecting Pulmonary Congestion in Heart Failure Patients
- A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial
- A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
- A Preliminary Study for INFORMED
- A Preventive, Multidisciplinary Primary Care Intervention Organized Around a Therapeutic Garden: Acceptability to Patients Suffering from Cardio-neurovascular Pathology and to Those Involved in the Action.
- A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- A Prospective, Observational, Single Centre Study to Assess the Feasibility of the Data Harvested by the Acorai Intracardiac Pressure Monitoring (ICPM) System in Predicting Prognosis in Patients Discharged From Hospital After Treatment for Acute Decompensated Heart Failure
- A Randomized Controlled Trial of LOT-CRT Versus conventionaL BiVP in Heart Failure Patients With NICD
- A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
- A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
- A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
- A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure
- A Study Investigating the Impact of IMT With CR On Exercise Responses In HF
- A Study Of Acute Decompensated Heart Failure
- A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
- A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants
- A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
- A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
- A Study of LY3971297 in Participants With Heart Failure
- A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- A Study of Metformin to Improve Cardiac Function After LVAD Implantation
- A Study of Paramedic HF Management
- A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart Failure
- A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- A Study to Evaluate Breathing Muscle Training in Cardiac Rehab
- A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions
- A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
- A Trial of CRD-4730 in HFrEF
- AI ECG Algorithm for Detecting LV Systolic Dysfunction
- AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices
- AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- AI-Guided Left Bundle Branch Area Pacing
- AI-Optimized Single-Feature Recognition Model for Heart Failure
- AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)
- AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- AMBulatory UltraSound for Heart Failure Management
- AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
- ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
- Ablate and Pace HIS Study
- Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
- Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
- Accelerated Pacing and Cardiac Filling Pressures During Exercise in Patients With Heart Failure With Preserved Ejection Fraction
- Acetazolamide Per os for Decompensation of Heart Failure
- Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients
- Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement
- Acute Heart Failure - COngestion Discharge Evaluation
- Acute Heart Failure Registry
- Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation
- Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation
- Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List
- Acute Response to Left Bundle Branch Area Pacing With SyncAV
- Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
- Add-on Diuretics in Acute Decompensated Heart Failure
- Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
- Aeson TAH System - Post-Market Clinical Follow-up Study
- AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure
- Alleviant ALLAY-HF Study
- Alleviant ALLAY-HFrEF Study
- Allograft Dysfunction in Heart Transplant
- An Evaluation of the KCCQ Score in Predicting Cardiovascular Risk in Dialysis Patients
- An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting
- Anesthesia for Catheter Aortic Valve ImplantATIOn Registry
- Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF
Related conditions
Trials recruiting for Heart failure often also study these conditions. Each links to its own recruiting-trial list.
Atrial fibrillation 535Heart Failure With Preserved Ejection Fraction 56Chronic kidney disease 588Hypertension 1201Heart Failure With Reduced Ejection Fraction 45Chronic Heart Failure 32Cardiovascular Diseases 164Cardiogenic Shock 25Obesity 1512Acute Heart Failure 24
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Heart failure trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.